New York’s Cannabis Control Board (CCB) held its third meeting yesterday, November 3, 2021. As will be the case with all CCB meetings, it was broadcast live and a transcript of the meeting will be published here.
We were pretty clear with what we were hoping for coming out of the CCB’s third meeting and Chairwoman Tremaine Wright’s statement that adult-use licenses will not be issued for 18 months: clarification on the licensure timeline (i.e. when rules and regulations will be released). That did not happen.
The CCB and the Office of Cannabis Management (OCM) did however make several noteworthy announcements, most notably implementing New York’s cannabinoid hemp rules and regulations. The CCB also approved a number of additional staffing hires. Details to come on the hires.
In terms of the cannabinoid hemp program, the CCB focused on highlighting the program objectives, particularly creating a comprehensive regulatory scheme and establishing consumer protections based on its rules and regulations for testing and packaging, among other things.
The CCB also announced future edits to the cannabinoid hemp regulations:
Changing the serving per milligram cap for dietary supplement cannabinoid hemp products from 75 mg to 100 mg; Removing the requirement that cannabinoid